Home > Financial Ratios > MARKSANS PHARMA

MARKSANS PHARMA
EV/Core EBITDA

    Back to All Ratios
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 15.6812.236.325.185.35

What is the latest EV/Core EBITDA ratio of MARKSANS PHARMA ?

The latest EV/Core EBITDA ratio of MARKSANS PHARMA is 15.68 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202515.68
Mar202412.23
Mar20236.32
Mar20225.18
Mar20215.35

How is EV/Core EBITDA of MARKSANS PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2025 15.68
28.21
Mar2024 12.23
93.51
Mar2023 6.32
22.01
Mar2022 5.18
-3.18
Mar2021 5.35 -

Other Financial Ratios of MARKSANS PHARMA


Compare EV/Core EBITDA ratio of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹8,332.1 Cr -14.4% -29.6% -4.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹393,383.0 Cr 2.6% -5.1% -6.4% Stock Analytics
DIVIS LABORATORIES ₹162,026.0 Cr -0.5% -10.1% 21.8% Stock Analytics
CIPLA ₹126,159.0 Cr 4.7% 4.8% -4.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,450.0 Cr 0.6% 5.2% 8.6% Stock Analytics
DR REDDYS LABORATORIES ₹104,536.0 Cr 4.3% -0.7% -11.4% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

-14.4%

-29.6%

-4.8%

SENSEX

-0%

-2.1%

1.1%


You may also like the below Video Courses